Taiwan FDA registration 367d12bc083643acbeca2a03cbb41c09

Cimosir Apixaban correction liquid and quality control fluid

TW: 希摩西爾 Apixaban校正液及品管液
Taiwan flagTaiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.·Registered Jul 18, 2018 – Jul 18, 2028Active
Registration details
Analysis ID
367d12bc083643acbeca2a03cbb41c09
Customs Code
DHA05603133507
Company information
Manufacturer Country
United States
Authorized Representative
Werfen Taiwan Limited
Product details
Intended Use
This product calibration solution can be used for correction by ACL TOP Family when performing Apixaban's Liquid Anti-Xa test. This product quality control liquid can be used for quality control when ACL TOP Family conducts Apixaban's Liquid Anti-Xa test.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1660 Quality control materials (analytical and non-analytical); A.1150 calibration
Import Information
import
Dates and status
Registration Date
Jul 18, 2018
Expiry Date
Jul 18, 2028
About this record

Access comprehensive regulatory information for Cimosir Apixaban correction liquid and quality control fluid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 367d12bc083643acbeca2a03cbb41c09 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices